Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice
Open accessAbstract
Alterations in the composition of the commensal microbiota (dysbiosis) seem to be a pathogenic component of functional gastrointestinal disorders, mainly irritable bowel syndrome (IBS), and might participate in the secretomotor and sensory alterations observed in these patients.We determined if a state antibiotics-induced intestinal dysbiosis is able to modify colonic pain-related and motor responses and characterized the neuro-immune mechanisms implicated in mice. A 2-week antibiotics treatment induced a colonic dysbiosis (increments in Bacteroides spp, Clostridium coccoides and Lactobacillus spp and reduction in Bifidobacterium spp). Bacterial adherence was not affected. Dysbiosis was associated with increased levels of secretory-IgA, up-regulation of the antimicrobial lectin RegIIIγ, and toll-like receptors (TLR) 4 and 7 and down-regulation of the antimicrobial-peptide Resistin-Like Molecule-β and TLR5. Dysbiotic mice showed less goblet cells, without changes in the thickness of the mucus layer. Neither macroscopical nor microscopical signs of inflammation were observed. In dysbiotic mice, expression of the cannabinoid receptor 2 was up-regulated, while the cannabinoid 1 and the mu-opioid receptors were down-regulated. In antibiotic-treated mice, visceral pain-related responses elicited by intraperitoneal acetic acid or intracolonic capsaicin were significantly attenuated. Colonic contractility was enhanced during dysbiosis. Intestinal dysbiosis induce changes in the innate intestinal immune system and modulate the expression of pain-related sensory systems, an effect associated with a reduction in visceral pain-related responses. Commensal microbiota modulates gut neuro-immune sensory systems, leading to functional changes, at least as it relates to viscerosensitivity. Similar mechanisms might explain the beneficial effects of antibiotics or certain probiotics in the treatment of IBS.
AI snapshot
Written from the paper’s full text.
TL;DR
A 2-week broad-spectrum antibiotic regimen in mice produced colonic dysbiosis, innate immune activation without overt inflammation, altered sensory receptor expression, reduced visceral pain-related responses, and increased colonic contractility. These findings suggest commensal microbiota modulates gut neuro-immune sensory and motor systems, with possible relevance to IBS.
Key findings
- Antibiotics induced colonic dysbiosis: total bacterial counts increased to 5.33 ± 0.54 × 10^13 vs 2.79 ± 0.38 × 10^13 cells/g feces (P = 0.004); Bacteroides spp. and C. coccoides increased 2- and 4-fold, Lactobacillus group increased 3-fold (P = 0.07), and Bifidobacterium spp. decreased 10-fold (P = 0.006). Cecum weight increased (507.7 ± 18.43 mg vs 409.0 ± 20.24 mg, P < 0.0009).
- Dysbiosis altered innate immune/host-bacterial markers without overt inflammation: s-IgA increased 10-fold (P < 0.05), RELMb was downregulated (P < 0.05), TLR7 was upregulated (P = 0.008), TLR5 was downregulated (P = 0.02), and goblet cell density decreased (158.8 ± 8.7 vs 187.2 ± 7.4 cells/mm, P < 0.05); no macroscopical or microscopical signs of inflammation were observed.
- Sensory and pain-related responses changed: CB1, MOR, and NGF were downregulated, while CB2 tended to increase. Visceral pain-related responses were attenuated: IP acetic acid-induced abdominal contractions were reduced by 33% (40.9 ± 7.6 vs 61.4 ± 4.0 per 30 min, P < 0.001), and intracolonic capsaicin-induced behaviors were reduced by 48% (12.9 ± 4.2 vs 25.1 ± 2.3 per 30 min, P < 0.05).
- Colonic contractility increased: spontaneous contractility AUC/10 min was 2.73 ± 0.46 g vs 1.60 ± 0.14 g (P < 0.05), and carbachol EC50 was 2.4-fold lower in antibiotic-treated mice (5.19 ± 1.59 × 10^-7 M vs 1.24 ± 0.30 × 10^-6 M, P = 0.056). Total bacterial counts correlated negatively with CB1 (r² = 0.39, P = 0.01) and TLR5 (r² = 0.36, P = 0.02), and positively with CB2 (r² = 0.31, P = 0.03) and TLR7 (r² = 0.32, P = 0.02).
Methods
- Female CD1 mice, 10–12 weeks old, were maintained in conventional conditions. Mice received a 2-week antibiotic mixture of bacitracin A, neomycin, and amphotericin B by daily oral gavage (0.3 mL) plus drinking water, or vehicle (deionized water); n = 28 per group, with subgroups used for visceral pain tests and in vitro colonic contractility.
- On day 15, 24 h after last treatment, animals were euthanized; colonic tissue and ceco-colonic fecal contents were collected. Analyses included qPCR for bacterial quantification, FISH for bacterial adherence, ELISA for secretory IgA, RT-qPCR for immune and sensory markers, histology, immunohistochemistry, organ bath contractility, and behavioral pain tests (IP acetic acid and intracolonic capsaicin).
- Statistical analysis used parametric unpaired t-tests or non-parametric Mann-Whitney tests as appropriate, Chi-square for bacterial adherence, and P < 0.05 for significance.
Limitations
- The paper states that immunohistochemical quantification was semiquantitative and should be further confirmed, that correlations should be interpreted with caution, and that further studies are needed to confirm relevance to IBS.
- The paper reports high variability that limited statistical significance for some measures, including the Lactobacillus increase (P = 0.07), RegIIIγ, TLR4, CB2, carbachol EC50, and L-NNA effects, which were trends or non-significant.
- Evident from the text: findings are from female CD1 mice using a single 2-week antibiotic regimen; no causal or translational experiments (e.g., probiotics, germ-free models, or human IBS samples) are reported, so mechanism and clinical relevance remain speculative.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 17 cited sources checked · 0 supported · 0 flagged
- Findingown data
In antibiotic-treated animals, CB1, MOR and NGF were selectively down-regulated.
“In antibiotic-treated animals, only a selective down-regulation of CB1, MOR and NGF was detected (Fig. 5A).”
Quote in the paperSubstantial claim - Findingown data
A 2-week antibiotic treatment induced a colonic dysbiosis in mice.
“A 2-week antibiotics treatment induced a colonic dysbiosis (increments in Bacteroides spp, Clostridium coccoides and Lactobacillus spp and reduction in Bifidobacterium spp).”
Quote in the paperSubstantial claim - Findingown data
Levels of secretory IgA were increased by 10-fold in antibiotic-treated animals.
“Levels of s-IgA were increased by 10-fold in antibiotic-treated animals (P < 0.05, Fig. 4A).”
Quote in the paperNot a substantial claim - Findingown data
In antibiotic-treated mice, RELMb was downregulated.
“In antibiotic-treated mice, RELMb was downregulated (P < 0.05 vs. vehicle group) while RegIIIg tended to be upregulated, although without reaching statistical significance (Fig. 4A).”
Quote in the paperNot a substantial claim - Findingown data
During antibiotic treatment, the ratio of C. coccoides (cluster XIVa) increased from about 15% in control conditions to approximately 35% of total counts.
“During antibiotic treatment the main change was an increase in the ratio of C. coccoides (cluster XIVa), from about 15% in control conditions to approximately 35% of the total counts.”
Quote in the paperSubstantial claim
- Findingown data
The 2-week period of antibiotic treatment did not affect the ratios of bacterial wall adherence.
“Overall, the 2-week period of antibiotic treatment did not affect the ratios of bacterial wall adherence (Table 1).”
Quote in the paperNot a substantial claim - Findingown data
IL-12p40 tended to be up-regulated in antibiotic-treated mice.
“Only IL-12p40 tended to be up-regulated in antibiotic-treated mice (P D 0.069, Fig. 4B).”
Quote in the paperNot a substantial claim - Findingown data
The Bifidobacteria group showed a 10-fold reduction in antibiotic-treated animals.
“On the other hand, the Bifidobacteria group showed a 10-fold reduction in antibiotic-treated animals (P D 0.006; Fig. 2).”
Quote in the paperSubstantial claim - Findingown data
Antibiotic-treated mice showed a higher proportion of coccoid-shaped Clostridia adhered to the colonic epithelium than vehicle-treated animals.
“Nevertheless, FISH images revealed that antibiotic-treated mice showed a higher proportion of coccoid-shaped Clostridia adhered to the epithelium than vehicle-treated animals, in which Clostridia hybridized mainly as a fusiform ballici (Fig. 3).”
Quote in the paperNot a substantial claim - Findingown data
In antibiotic-treated mice, RegIIIg tended to be upregulated without reaching statistical significance.
“In antibiotic-treated mice, RELMb was downregulated (P < 0.05 vs. vehicle group) while RegIIIg tended to be upregulated, although without reaching statistical significance (Fig. 4A).”
Quote in the paperNot a substantial claim - Findingown data
No differences in the expression of pro- or anti-inflammatory cytokines were observed between vehicle- and antibiotic-treated animals.
“No differences in the expression of pro-(IL-6, IL-12p40 and TNFa) or anti-inflammatory (IL-10) cytokines was observed between vehicle-and antibiotic-treated animals.”
Quote in the paperNot a substantial claim - Findingown data
No differences in iNOS expression were observed between vehicle- and antibiotic-treated mice.
“In the present conditions, no differences in iNOS expression were observed between vehicle-and antibiotic-treated mice (P D 0.1982; Fig. 4B).”
Quote in the paperNot a substantial claim - Findingown data
Total bacterial counts were increased in antibiotic-treated mice for a 2-week period compared with vehicle-treated animals.
“Total bacterial counts were increased in antibiotic-treated mice for a 2-week period when compared with the counts in vehicle-treated animals (5.33 § 0.54 £ 10 13 cells/g of feces vs. Two.79§ 0.38 £ 10 13 cells/g of feces; P D 0.004).”
Quote in the paperSubstantial claim - Findingown data
CB2 expression showed a tendency to be upregulated in antibiotic-treated animals, without statistical significance.
“CB2 expression showed a tendency to be upregulated; however, statistical significance was not reached probably because of the relatively high variability observed in antibiotic-treated animals.”
Quote in the paperNot a substantial claim - Findingown data
The number of CB2-positive ganglionic cells was increased by 13% in antibiotic-treated animals.
“On the other hand, the number of CB2-positive ganglionic cells was increased by 13% in antibiotic-treated animals (Fig. 5B).”
Quote in the paperNot a substantial claim - Findingown data
Intracolonic capsaicin-induced pain-related behaviors were reduced by 48% in antibiotic-treated mice compared with vehicle-treated mice.
“Capsaicin-induced pain-related behaviors were reduced by 48% in antibiotic-treated mice (12.9 § 4.2 behaviors/30 min, n D 6) when compared to vehicle-treated mice (25.1 § 2.3 behaviors/30 min, n D 6; P < 0.05; Fig. 7B).”
Quote in the paperSubstantial claim - Findingown data
Intraperitoneal acetic acid-induced visceral pain-related responses were attenuated by 33% in antibiotic-treated mice compared with vehicle-treated animals.
“Timecourse responses to IP acetic acid were similar in vehicleand antibiotic-treated mice, but the overall response was attenuated by 33% in antibiotics-treated mice (40.9 § 7.6 abdominal contractions/ 30 min, n D 6) when compared to vehicle treated animals (61.4 § 4.0 abdominal contractions/ 30 min, n D 6; P < 0 .001;Fig. 7A).”
Quote in the paperSubstantial claim - Findingown data
Spontaneous colonic contractility during L-NNA addition had a tendency to be higher in antibiotic-treated mice compared with vehicle controls.
“Spontaneous colonic contractility during L-NNA addition to the organ bath, to block NO synthesis, had a tendency to be higher in antibiotic-treated mice (AUC/10 min: 10.37 § 2.77 g, n D 6) compared with vehicle controls (AUC: 4.88 § 0.82 g, n D 5; P D 0.0578; Fig. 8).”
Quote in the paperNot a substantial claim - Findingown data
Antibiotic-treated mice showed a reduction in the density of goblet cells per crypt length compared with vehicle-treated mice.
“Evaluation of PAS/AB-stained sections showed a reduction in the density of goblet cells (per crypt length) in antibiotic-treated animals (158.8 § 8.7 cells mm ¡1 , n D 8) compared with the vehicle-treated group (187.2 § 7.4 cells mm ¡1 , n D 7, P < 0 .05;Fig. 1B).”
Quote in the paperNot a substantial claim - Findingown data
No significant differences in final histopathological scores were observed between vehicle- and antibiotic-treated mice.
“No significant differences in the final histopathological scores (vehicle: 0.66 § 0.25; antibiotic: 1.27 § 0.25; n D 7-8 per group) were observed (Fig. 1A).”
Quote in the paperNot a substantial claim - Findingown data
The 2-week antibiotic treatment caused enlargement of the cecum in mice.
“At necropsy, the only significant change observed was the enlargement of the cecum in antibiotictreated animals (507.7 § 18.43 mg, P < 0.0009 vs. vehicle group: 409.0 § 20.24 mg; n D 19 for each).”
Quote in the paperNot a substantial claim - Findingown data
The EC50 for carbachol was 2.4-fold lower in antibiotic-treated mice than in controls.
“In antibiotic-treated mice the EC 50 for carbachol was 2.4-fold lower than that determined in control conditions (vehicle: 1.24 § 0.30 10 ¡6 M; antibiotic: 5.19 § 1.59 10 ¡7 M; n D 5-6; P D 0.056; Fig. 8).”
Quote in the paperSubstantial claim - Findingown data
No differences were observed for the thickness of the mucus layer.
“No differences were observed for the thickness of the mucus layer (Fig. 1D).”
Quote in the paperNot a substantial claim - Findingown data
Spontaneous colonic contractility was increased in antibiotic-treated mice compared with vehicle-treated animals.
“Spontaneous colonic contractility, as assessed in vitro, was increased in the antibiotic-treated group (AUC/10 min: 2.73 § 0.46 g, n D 6) when compared to vehicle-treated animals (AUC/ 10 min: 1.60 § 0.14 g, n D 5; P < 0.05; Fig. 8).”
Quote in the paperSubstantial claim - Findingown data
In antibiotic-treated mice, C. coccoides (cluster XIVa) adherence to the colonic wall was observed in 6/7 (85.7%) of animals.
“Antibiotic | 0/7 (0%) | 2/7 (28.6%) | 0/7 (0%) | 6/7 (85.7%) | 1/7 (14.3%) | 1/7 (14.3%) | 2/7 (28.6%)”
Quote in the paperSubstantial claim - Findingown data
In antibiotic-treated mice, Verrucobacteria adherence to the colonic wall was observed in 0/7 (0%) of animals.
“Antibiotic | 0/7 (0%) | 2/7 (28.6%) | 0/7 (0%) | 6/7 (85.7%) | 1/7 (14.3%) | 1/7 (14.3%) | 2/7 (28.6%)”
Quote in the paperNot a substantial claim - Findingown data
Antibiotic treatment significantly altered the total number of acetic acid-induced abdominal contractions compared with vehicle-AA group (P < 0.05).
“Effects of antibiotic treatment on visceral pain-related responses.”
- Also stated in: § Disclosure of Potential Conflicts of Interest · plain
“#: P < 0.05 vs. vehicle-AA group.”
Quote in the paperSubstantial claim - Also stated in: § Disclosure of Potential Conflicts of Interest · plain
- Findingown data
Clostridium spp (identified by FISH using the EREC 482 probe) adhere to the colonic epithelium.
“Representative colonic tissue images showing Clostridium spp (identified by FISH using the EREC 482 probe) adherence to the colonic epithelium.”
Quote in the paperNot a substantial claim - Findingown data
In vehicle-treated mice, C. coccoides (cluster XIVa) adherence to the colonic wall was observed in 8/8 (100%) of animals.
“Vehicle | 1/8 (12.5%) | 3/8 (37.5%) | 0/8 (0%) | 8/8 (100%) | 1/8 (12.5%) | 0/8 (0%) | 2/8 (25%)”
Quote in the paperNot a substantial claim - Findingown data
In vehicle-treated, antibiotic-treated, and non-treated naïve mice, abundant bacteria were observed attached to the colonic epithelium.
“In all cases (A-C) abundant bacteria was observed attached to the colonic epithelium.”
Quote in the paperNot a substantial claim - Findingown data
In antibiotic-treated mice, Bacteroides spp. adherence to the colonic wall was observed in 0/7 (0%) of animals.
“Antibiotic | 0/7 (0%) | 2/7 (28.6%) | 0/7 (0%) | 6/7 (85.7%) | 1/7 (14.3%) | 1/7 (14.3%) | 2/7 (28.6%)”
Quote in the paperSubstantial claim - Findingown data
In antibiotic-treated mice, segmented filamentous bacteria adherence to the colonic wall was observed in 2/7 (28.6%) of animals.
“Antibiotic | 0/7 (0%) | 2/7 (28.6%) | 0/7 (0%) | 6/7 (85.7%) | 1/7 (14.3%) | 1/7 (14.3%) | 2/7 (28.6%)”
Quote in the paperNot a substantial claim - Findingown data
In vehicle-treated mice, Lactobacillus-Enterococcus spp. adherence to the colonic wall was observed in 1/8 (12.5%) of animals.
“Vehicle | 1/8 (12.5%) | 3/8 (37.5%) | 0/8 (0%) | 8/8 (100%) | 1/8 (12.5%) | 0/8 (0%) | 2/8 (25%)”
Quote in the paperNot a substantial claim - Findingown data
Intracolonic capsaicin induced visceral pain-related behaviors in mice compared with non-capsaicin-treated controls (P < 0.001).
“B: Intracolonic capsaicin-(Caps) evoked visceral pain-related behaviors.”
- Also stated in: § Disclosure of Potential Conflicts of Interest · plain
“***: P < 0.001 vs. respective non-capsaicin-treated control group.”
Quote in the paperSubstantial claim - Also stated in: § Disclosure of Potential Conflicts of Interest · plain
- Findingown data
In antibiotic-treated mice, Lactobacillus-Enterococcus spp. adherence to the colonic wall was observed in 1/7 (14.3%) of animals.
“Antibiotic | 0/7 (0%) | 2/7 (28.6%) | 0/7 (0%) | 6/7 (85.7%) | 1/7 (14.3%) | 1/7 (14.3%) | 2/7 (28.6%)”
Quote in the paperNot a substantial claim - Findingown data
In vehicle-treated mice, Bacteroides spp. adherence to the colonic wall was observed in 1/8 (12.5%) of animals.
“Vehicle | 1/8 (12.5%) | 3/8 (37.5%) | 0/8 (0%) | 8/8 (100%) | 1/8 (12.5%) | 0/8 (0%) | 2/8 (25%)”
Quote in the paperNot a substantial claim - Findingown data
In vehicle-treated mice, Enterobacteria adherence to the colonic wall was observed in 3/8 (37.5%) of animals.
“Vehicle | 1/8 (12.5%) | 3/8 (37.5%) | 0/8 (0%) | 8/8 (100%) | 1/8 (12.5%) | 0/8 (0%) | 2/8 (25%)”
Quote in the paperNot a substantial claim - Findingown data
In antibiotic-treated mice, Bifidobacterium spp. adherence to the colonic wall was observed in 1/7 (14.3%) of animals.
“Antibiotic | 0/7 (0%) | 2/7 (28.6%) | 0/7 (0%) | 6/7 (85.7%) | 1/7 (14.3%) | 1/7 (14.3%) | 2/7 (28.6%)”
Quote in the paperNot a substantial claim - Findingown data
Antibiotic treatment significantly altered the total number of capsaicin-evoked visceral pain-related behaviors compared with vehicle-Caps group (P < 0.05).
“Effects of antibiotic treatment on visceral pain-related responses.”
- Also stated in: § Disclosure of Potential Conflicts of Interest · plain
“#: P < 0.05 vs. vehicle-Caps group.”
Quote in the paperSubstantial claim - Also stated in: § Disclosure of Potential Conflicts of Interest · plain
- Findingown data
Intraperitoneal acetic acid (0.6%) induced abdominal contractions in mice compared with non-AA-treated controls (P < 0.001).
“A: Intraperitoneal acetic acid-(AA, 0.6%) induced abdominal contractions.”
- Also stated in: § Disclosure of Potential Conflicts of Interest · plain
“***: P < 0 .001vs. respective non-AA-treated control group.”
Quote in the paperSubstantial claim - Also stated in: § Disclosure of Potential Conflicts of Interest · plain
- Findingown data
In vehicle-treated mice, Bifidobacterium spp. adherence to the colonic wall was observed in 0/8 (0%) of animals.
“Vehicle | 1/8 (12.5%) | 3/8 (37.5%) | 0/8 (0%) | 8/8 (100%) | 1/8 (12.5%) | 0/8 (0%) | 2/8 (25%)”
Quote in the paperNot a substantial claim - Findingown data
In antibiotic-treated mice, Enterobacteria adherence to the colonic wall was observed in 2/7 (28.6%) of animals.
“Antibiotic | 0/7 (0%) | 2/7 (28.6%) | 0/7 (0%) | 6/7 (85.7%) | 1/7 (14.3%) | 1/7 (14.3%) | 2/7 (28.6%)”
Quote in the paperNot a substantial claim - Premisecitation
TLR4 is mainly activated by lipopolysaccharides (LPS) from Gram negative bacteria.
“On the other hand, TLR4 is mainly activated by lipopolysaccharides (LPS) from Gram negative bacteria.37”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [37] source
Not checked in the free run.
- Premisecitation
Specific alterations in the composition of the GCM modify the expression of the intestinal endocannabinoid system, affecting nociceptive responses in mice.
“For instance, we have recently shown that specific alterations in the composition of the GCM modify the expression of the intestinal endocannabinoid system, affecting nociceptive responses in mice.19”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [19] source
Not checked in the free run.
- Interpretationreasoning
Commensal microbiota modulates gut neuro-immune sensory systems, leading to functional changes, at least as it relates to viscerosensitivity.
“Commensal microbiota modulates gut neuro-immune sensory systems, leading to functional changes, at least as it relates to viscerosensitivity.”
Quote in the paperSubstantial claim - Interpretationown data
During dysbiosis, enhanced colonic contractility represents an imbalance between excitatory (mainly cholinergic) and inhibitory (mainly NO-dependent) systems.
“This, together with the observed increased responses to carbachol and NO-synthase (neural and endothelial) inhibition suggests that during dysbiosis enhanced colonic contractility represents an imbalance between excitatory (mainly cholinergic) and inhibitory (mainly NO-dependent) systems.”
Quote in the paperSubstantial claim - Interpretationown data
The innate immune activation was not associated with structural changes consistent with a state of overt inflammation within the colon.
“Interestingly, this innate immune activation was not associated to structural changes (macroscopical or microscopical) consistent with a state of overt inflammation within the colon.”
Quote in the paperSubstantial claim - Interpretationreasoning
Altered gut microbiota might be responsible, at least in part, for the colonic motor disturbances observed in IBS patients.
“Overall, these observations suggest that altered gut microbiota might be responsible, at least in part, for the colonic motor disturbances observed in IBS patients and might help to explain the beneficial effects observed after antibiotic or probiotic treatments.”
Quote in the paperSubstantial claim - Premisecitation
Microbiota and microbial-derived products are factors that also affect gastrointestinal motility.
“The microbiota and microbial-derived products are factors that also affect gastrointestinal motility.53,54”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationreasoning
The antibiotic treatment favored the expansion of antibiotic-resistant bacterial groups.
“In the present conditions, total bacterial load was increased in antibiotic-treated animals; thus suggesting that the treatment favored the expansion of antibiotic-resistant bacterial groups.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The slight TLR4 upregulation observed might represent an adaptive response to the proliferation of Bacteroides spp.
“Therefore, in our conditions, the slight TLR4 upregulation observed might represent and adaptive response to the proliferation of Bacteroides spp.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The changes in host-bacterial interaction and local neuroimmune systems lead to functional alterations revealed as changes in colonic sensitivity and contractility.
“These changes imply a modulation of both host-bacterial interaction systems and local neuroimmune systems, leading to functional alterations revealed as changes in colonic sensitivity and contractility.”
Quote in the paperSubstantial claim - Interpretationreasoning
NGF downregulation might contribute to the analgesic-like responses observed.
“Therefore, NGF downregulation might also contribute to the analgesic-like responses observed here.”
Quote in the paperNot a substantial claim - Interpretationown data
Gene expression changes translated at the protein level, since CB1, CB2 and MOR immunoreactivity in the enteric nervous system was also modified in the same direction as the gene expression.
“Moreover, gene expression changes translated at the protein level, since CB1, CB2 and MOR immunoreactivity in the enteric nervous system was also modified in the same direction as the gene expression.”
Quote in the paperSubstantial claim - Premisecitation
Several studies linking the gut microbiota with visceral sensitivity have shown that increments in the Lactobacilli family are associated to visceral analgesic-like states.
“Moreover, several studies linking the gut microbiota with visceral sensitivity, have shown that increments in the Lactobacilli family (during probiotic treatment or during states of dysbiosis) are associated to visceral analgesic-like states.18,19,21,33”
Quote in the paperSubstantial claim0 of 4 sources checked
- May combine two claims. 19
- The quote only partly states this claim. 2
- Classified as probably not a substantial claim. 21
May combine two claims.
Findingown dataThe Lactobacilli group was increased by 3-fold after the antibiotic treatment, although statistical significance was not reached.
“Similarly, the Lactobacilli group was increased by 3-fold after the antibiotic treatment, although statistical significance was not reached, probably because of the relative large variability observed in control conditions (P D 0.07; Fig. 2).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn antibiotic-treated animals, TLR7 was significantly upregulated, TLR4 tended to be upregulated, and TLR5 was slightly downregulated.
“In antibiotic-treated animals specific changes in expression were detected; with a significant upregulation of TLR7 (P D 0.008) and a tendency for TLR4 (P D 0.08); while TLR5 showed a slight (less than 1-fold) downregulation (P D 0.02) (Fig. 4C).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe antibiotic treatment increased Bacteroides spp. and Clostridium coccoides counts by 2- and 4-fold, respectively.
“The treatment with antibiotics increased Bacteroides spp.and Clostridium coccoides counts by 2-and 4-fold, respectively (both P < 0.05; Fig. 2).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe number of CB1- or MOR-positive ganglionic cells within the myenteric plexus was reduced by 25% and 30%, respectively, in antibiotic-treated mice.
“The number of CB1-or MOR-positive ganglionic cells within the myenteric plexus was reduced by 25% and 30%, respectively, in antibiotics-treated mice.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataTLR7 expression correlated positively with CB2, TRPV1 and TRPV3 and negatively with MOR.
“Moreover, regardless the treatment applied, positive correlations between TLR7 and the nociceptive markers CB2 (P D 0.0001; r 2 D 0.79), TRPV1 (P D 0.005; r 2 D 0.45) and TRPV3 (P D 0.0008; r 2 D 0.59) were found, while negatively correlating with MOR expression (P D 0.01; r 2 D 0.39) (Fig. 6B).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIL-12p40 and IL-10 expression correlated positively with TLR7 expression.
“In addition, expression levels of IL-12p40 (P D 0.0008; r 2 D 0.59) and IL-10 (P D 0.003; r 2 D 0.49) correlated positively with TLR7 expression.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataNeither macroscopical nor microscopical signs of inflammation were observed in antibiotic-treated mice.
“Neither macroscopical nor microscopical signs of inflammation were observed.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataTotal bacterial counts correlated negatively with colonic expression of CB1 and TLR-5 and positively with CB2 and TLR-7.
“Total bacterial counts correlated negatively with the colonic expression of CB1 (P D 0.01; r 2 D 0.39) and TLR-5 (P D 0.02; r 2 D 0.36) and positively with CB2 (P D 0.03; r 2 D 0.31) and TLR-7 (P D 0.02; r 2 D 0.32) (Fig. 6A).”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Findingown dataIn antibiotic-treated mice, a shift in bacterial morphology to abundant coccoidal forms attached to the colonic epithelium was observed.
“while in antibiotic-treated animals (B) a shift in morphology, with the appearance of abundant coccoidal forms, can be observed.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataIn vehicle-treated mice, Verrucobacteria adherence to the colonic wall was observed in 0/8 (0%) of animals.
“Vehicle | 1/8 (12.5%) | 3/8 (37.5%) | 0/8 (0%) | 8/8 (100%) | 1/8 (12.5%) | 0/8 (0%) | 2/8 (25%)”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataBacillary-shaped bacteria were observed attached to the colonic epithelium in vehicle-treated mice and non-treated naïve mice.
“bacillary-shaped bacteria were observed in vehicle-treated animals (A) (similarly to that observed in the non-treated na€ ıve animal, (C)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataIn vehicle-treated mice, segmented filamentous bacteria adherence to the colonic wall was observed in 2/8 (25%) of animals.
“Vehicle | 1/8 (12.5%) | 3/8 (37.5%) | 0/8 (0%) | 8/8 (100%) | 1/8 (12.5%) | 0/8 (0%) | 2/8 (25%)”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationNGF has been implicated in the sensitization of visceral afferents, leading to the development of hypersensitivity.
“Additionally, NGF has been implicated in the sensitization of visceral afferents, leading to the development of hypersensitivity.46”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [46] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAll FISH procedures were performed on coded slides to avoid bias.
“All procedures were performed on coded slides, to avoid bias.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningDuring states of dysbiosis there is a local neuro-immune adaptive response, likely associated to changes in host-bacterial interactions, which leads to functional alterations manifested as changes in viscerosensitivity and motor activity within the colon.
“In summary, the results presented here indicate that during states of dysbiosis there is a local neuro-immune adaptive response, likely associated to changes in host-bacterial interactions, which leads to functional alterations manifested as changes in viscerosensitivity and motor activity within the colon.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
PremisecitationCannabinoid receptors and MOR are directly involved in visceral pain, eliciting analgesic responses.
“Cannabinoid receptors and MOR are directly involved in visceral pain, eliciting analgesic responses.42,44”
Quote in the paperSubstantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). The quote only partly states this claim.
Study design and conductnone givenAll samples, as well as the negative controls, were assayed in triplicate for RT-qPCR.
“All samples, as well as the negative controls, were assayed in triplicate.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenHistopathological scoring was performed on coded slides by two independent researchers.
“Scoring was performed on coded slides by 2 independent researchers.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationRecent evidences have linked activation of TLRs, particularly TLR-4, with changes in nociception.
“Recent evidences have linked activation of TLRs, particularly TLR-4, with changes in nociception.47,48”
Quote in the paperNot a substantial claim0 of 2 sources checkedClassified as probably not a substantial claim. May combine two claims.
PremisecitationIn IBS patients, intestinal dysbiosis with altered host-microbial interactions seems to be important generating a local immune response that might lead to the sensorial and secretomotor alterations characteristic of the disease.
“For instance, in IBS patients, intestinal dysbiosis with altered hostmicrobial interactions seems to be important generating a local immune response that might lead to the sensorial and secretomotor alterations characteristic of the disease.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [18][19][20][21]
Not checked in the free run.
Probably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing).
PremisecitationDirect TLR4-dependent host-bacterial interactions enhance motility through a neutrally-mediated effect.
“Similarly, it has been suggested that direct TLR4-dependent host-bacterial interactions enhance motility through a neutrallymediated effect.53”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [53] source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe down-regulation of MOR and CB1 contrasts with the analgesic-like state observed, an effect likely compensated by the moderate up-regulation of CB2.
“Therefore, the down-regulation of MOR and CB1 contrasts with the analgesic-like state observed, an effect likely compensated by the moderate up-regulation of CB2, which has been implicated in pain modulation in states of inflammation and immune activation.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenAll procedures were approved by the Ethical Committee of the Universitat Autonoma de Barcelona and the Generalitat de Catalunya.
“All procedures were approved by the Ethical Committee of the Universitat Aut onoma de Barcelona (protocols 1099 and 1396) and the Generalitat de Catalunya (protocols 5646 and 7193).”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductcitationRelative abundance of bacteria was measured using 16S rRNA gene-targeting hydrolysis probes as previously described.
“The relative abundance of bacteria was measured using 16S rRNA gene-targeting hydrolysis probes (Custom TaqMan assays; Applied Biosystems) as previously described.[58][59][60]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [58][59][60]
Not checked in the free run.
May combine two claims.
Interpretationown dataIntestinal dysbiosis induces changes in the innate intestinal immune system and modulates the expression of pain-related sensory systems, an effect associated with a reduction in visceral pain-related responses.
“Intestinal dysbiosis induce changes in the innate intestinal immune system and modulate the expression of pain-related sensory systems, an effect associated with a reduction in visceral painrelated responses.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataTLRs act as transducers of microbial-generated signals generating local changes in neuroimmune systems and leading to a modulation of viscerosensitivity.
“Although these correlations have to be interpreted with caution, this further supports the possibility that TLRs act as transducers of microbial-generated signals generating local changes in neuroimmune systems and leading to a modulation of viscerosensitivity.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningModulation of cannabinoid and opioid pathways might be important in host-bacterial interactions and might mediate neural-related functional changes associated with alterations of the GCM.
“In any case, these observations indicate that modulation of cannabinoid and opioid pathways might be important in host-bacterial interactions and might mediate neural-related functional changes associated to alterations of the GCM.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationAlterations in the normal composition of GCM, known as intestinal dysbiosis, have been linked to several diseases of the GI tract, including inflammatory conditions and IBS.
“Alterations in the normal composition of GCM, known as intestinal dysbiosis, have been linked to several diseases of the GI tract, including inflammatory conditions and IBS.2,[13][14][15][16][17][18]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites 2,[13][14][15][16][17][18]
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe observed changes indicate an activation of the innate immune system, which might be related to the dysbiotic state.
“Overall, these changes indicate an activation of the innate immune system, which might be related to the dysbiotic state.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAll samples and negative controls were assayed in triplicates.
“All samples and the negative controls were assayed in triplicates.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenEach animal was used only for one procedure.
“Each animal was used only for one procedure.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenA coincidence between the two observers in bacterial location in at least 15% of the pictures observed (at least 3 out of 20) was required to decide that there was bacterial attachment to the epithelium.
“A coincidence between the 2 observers in bacterial location in at least 15% of the pictures observed (at least 3 out of 20) was required to decide that there was bacterial attachment to the epithelium.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataVisceral pain-related responses elicited by intraperitoneal or direct intracolonic chemical stimulation were attenuated by 40% in antibiotic-treated mice, suggesting that treatment with antibiotics can generate an analgesic-like state within the gut.
“Indeed, visceral pain-related responses elicited by intraperitoneal or direct intracolonic chemical stimulation were attenuated by 40% in antibiotic-treated mice, thus suggesting that treatment with antibiotics can generate an analgesic-like state within the gut.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataMeasurements of mucous layer thickness were performed on coded slides by two independent investigators.
“All measurements were performed on coded slides by 2 independent investigators using the Zeiss AxioVision Release 4.8.1 software.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe pain response to intraperitoneal acetic acid was scored by counting abdominal contractions by two independent researchers.
“The pain response was scored by counting the number of abdominal contractions during the 30 min period after the IP treatment (in blocks of 5 min) by 2 independent researchers.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenPain behaviors were visually assessed by two independent researchers.
“Pain behaviors were visually assessed by 2 independent researchers.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAll immunohistochemistry procedures were performed on coded slides to avoid bias.
“All procedures were performed on coded slides to avoid any bias.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataSpecificity of immunohistochemical staining was confirmed by omission of the primary antibody.
“Specificity of staining was confirmed by omission of the primary antibody.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
The effects of the antibiotic treatment on colonic sensory and motor responses are mediated by the induced dysbiosis rather than by direct effects of antibiotics on the host.
“Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice”
The paper relies on this without support.
The antibiotic-induced dysbiosis in mice is a valid model for the dysbiosis and neuro-immune changes in IBS patients.
“Similar mechanisms might explain the beneficial effects of antibiotics or certain probiotics in the treatment of IBS.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Gut microbiota may directly modulate several systems involved in visceral hypersensitivity.
“Recent data have shown that gut microbiota may directly modulate several systems involved in visceral hypersensitivity.”
From Gut microbiota role in irritable bowel syndrome: New therapeutic strategies (2016) · cites this paper as [115]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Mixed-mucin goblet cells described as increased despite lower count
MajorThe text calls this a relative increase in antibiotic-treated mice, but reports 21.1 cells per unit length in that group versus 28.5 in the vehicle group-a decrease.
“antibiotic-treated mice showed a relative increase in the number of goblet cells containing a mixture of acidic and neutral mucins”
“(antibiotic: 21.1 § 1.9 cells mm ¡1 ; vehicle: 28.5 § 2.0 cells mm ¡1 ; P < 0.05; Fig. 1B)”
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860 · see citing works
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,820 · see citing works
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837 · see citing works
The gut flora as a forgotten organ
O'Hara, A. M., & Shanahan, F. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400731 · Cited by 2,791 · see citing works
Control of pathogens and pathobionts by the gut microbiota
Kamada, N., Chen, G. Y., Inohara, N., & Núñez, G. (2013) · Nature Immunology · doi:10.1038/ni.2608 · Cited by 1,625 · see citing works
Abreu, M. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2707 · Cited by 1,288 · see citing works
Enteric defensins are essential regulators of intestinal microbial ecology
Salzman, N. H., Hung, K., Haribhai, D., Chu, H., Karlsson-Sjöberg, J., Amir, E., Teggatz, P., Barman, M., Hayward, M., Eastwood, D., et al. (2010) · Nature Immunology · doi:10.1038/ni.1825 · Cited by 1,156 · see citing works
Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut
Artis, D. (2008) · Nature reviews. Immunology · doi:10.1038/nri2316 · Cited by 1,136 · see citing works
Microbial modulation of innate defense: goblet cells and the intestinal mucus layer
Deplancke, B., & Gaskins, H. R. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.6.1131s · Cited by 1,012 · see citing works
Intestinal microbiota in functional bowel disorders: a Rome foundation report
Simrén, M., Barbara, G., Flint, H. J., Spiegel, B. M. R., Spiller, R. C., Vanner, S., Verdu, E. F., Whorwell, P. J., & Zoetendal, E. G. (2013) · Gut · doi:10.1136/gutjnl-2012-302167 · Cited by 939 · see citing works
Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors
Rousseaux, C., Thuru, X., Gelot, A., Barnich, N., Neut, C., Dubuquoy, L., Dubuquoy, C., Merour, E., Geboes, K., Chamaillard, M., et al. (2007) · Nature Medicine · doi:10.1038/nm1521 · Cited by 793 · see citing works
Eradication of Small Intestinal Bacterial Overgrowth Reduces Symptoms of Irritable Bowel Syndrome
Pimentel, M., Chow, E. J., & Lin, H. C. (2000) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03368.x · Cited by 780 · see citing works
The immune system and the gut microbiota: friends or foes?
Cerf-Bensussan, N., & Gaboriau-Routhiau, V. (2010) · Nature Reviews Immunology · doi:10.1038/nri2850 · Cited by 704 · see citing works
Collins, S. M., & Bercik, P. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.075 · Cited by 612 · see citing works
Regulation of the stress response by the gut microbiota: implications for psychoneuroendocrinology
Dinan, T. G., & Cryan, J. F. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.03.007 · Cited by 577 · see citing works
Depletion of Murine Intestinal Microbiota: Effects on Gut Mucosa and Epithelial Gene Expression
Reikvam, D. H., Erofeev, A. S., Sandvik, A., Grcic, V., Jahnsen, F. L., Gaustad, P., McCoy, K. D., Macpherson, A. J., Meza‐Zepeda, L. A., & Johansen, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017996 · Cited by 531 · see citing works
TRPA1 channels mediate acute neurogenic inflammation and pain produced by bacterial endotoxins
Meseguer, V., Alpizar, Y. A., Luis, E., Tajada, S., Denlinger, B., Fajardo, O., Manenschijn, J.-A., Fernández-Peña, C., Talavera, A., Kichko, T., et al. (2014) · Nature Communications · doi:10.1038/ncomms4125 · Cited by 479 · see citing works
Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice
Verdú, E. F., Bercik, P., Verma-Gandhu, M., Huang, X.-X., Blennerhassett, P., Jackson, W., Mao, Y., Wang, L., Rochat, F., & Collins, S. M. (2006) · Gut · doi:10.1136/gut.2005.066100 · Cited by 448 · see citing works
Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR
Furet, J., Firmesse, O., Gourmelon, M., Bridonneau, C., Tap, J., Mondot, S., Dore, J. M., & Corthier, G. (2009) · FEMS Microbiology Ecology · doi:10.1111/j.1574-6941.2009.00671.x · Cited by 431 · see citing works
Hill, D. A., Hoffmann, C., Abt, M. C., Du, Y., Kobuley, D. E., Kirn, T. J., Bushman, F. D., & Artis, D. (2009) · Mucosal Immunology · doi:10.1038/mi.2009.132 · Cited by 425 · see citing works
Immune Responses to the Microbiota at the Intestinal Mucosal Surface
Duerkop, B. A., Vaishnava, S., & Hooper, L. V. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.009 · Cited by 424 · see citing works
Extensive Set of 16S rRNA-Based Probes for Detection of Bacteria in Human Feces
Harmsen, H. J. M., Raangs, G. C., He, T., Degener, J. E., & Welling, G. W. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.6.2982-2990.2002 · Cited by 401 · see citing works
Gut microbial products regulate murine gastrointestinal motility via Toll-like receptor 4 signaling
Anitha, M., Vijay–Kumar, M., Sitaraman, S. V., Gewirtz, A. T., & Srinivasan, S. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.034 · Cited by 397 · see citing works
Wlodarska, M., Willing, B., Keeney, K. M., Menendez, A., Bergstrom, K. S., Gill, N., Russell, S. L., Vallance, B. A., & Finlay, B. B. (2011) · Infection and Immunity · doi:10.1128/iai.01104-10 · Cited by 382 · see citing works
GUYONNET, D., CHASSANY, O., DUCROTTE, P., PICARD, C., MOURET, M., MERCIER, C. ‐., & MATUCHANSKY, C. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03362.x · Cited by 365 · see citing works
Söderholm, J. D., Yang, P., Ceponis, P., Vohra, A., Riddell, R., Sherman, P. M., & Perdue, M. H. (2002) · Gastroenterology · doi:10.1053/gast.2002.36019 · Cited by 362 · see citing works
Jalanka-Tuovinen, J., Salojärvi, J., Salonen, A., Immonen, O., Garsed, K., Kelly, F. M., Zaitoun, A., Palva, A., Spiller, R. C., & de Vos, W. M. (2014) · Gut · doi:10.1136/gutjnl-2013-305994 · Cited by 340 · see citing works
Interactions Between Commensal Bacteria and Gut Sensorimotor Function in Health and Disease
Barbara, G., Stanghellini, V., Brandi, G., Cremon, C., Nardo, G. D., De Giorgio, R., & Corinaldesi, R. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00230.x · Cited by 325 · see citing works
Haarman, M., & Knol, J. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.72.4.2359-2365.2006 · Cited by 321 · see citing works
Swidsinski, A. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i8.1131 · Cited by 314 · see citing works
The microbiota–gut–brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both?
Palma, G. D., Collins, S. M., Berčík, P., & Verdu, E. F. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.273995 · Cited by 293 · see citing works
Guglielmetti, S., Mora, D., Gschwender, M., & Popp, K. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04633.x · Cited by 287 · see citing works
Croswell, A., Amir, E., Teggatz, P., Barman, M., & Salzman, N. H. (2009) · Infection and Immunity · doi:10.1128/iai.00006-09 · Cited by 272 · see citing works
Xu, D., Gao, J., Gillilland, M., Wu, X., Song, I., Kao, J. Y., & Owyang, C. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.10.026 · Cited by 271 · see citing works
Wright, K. L., Duncan, M., & Sharkey, K. A. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707486 · Cited by 269 · see citing works
A role for inflammation in irritable bowel syndrome?
Barbara, G., GIORGIO, R. D., Stanghellini, V., Cremon, C., & Corinaldesi, R. (2002) · Gut · doi:10.1136/gut.51.suppl_1.i41 · Cited by 266 · see citing works
Domínguez, P. M., & Ardavı́n, C. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00876.x · Cited by 254 · see citing works
Salzman, N. H., de Jong, H., Paterson, Y. Y. W., Harmsen, H. J. M., Welling, G. W., & Bos, N. A. (2002) · Microbiology · doi:10.1099/00221287-148-11-3651 · Cited by 253 · see citing works
The intestinal microbiome, probiotics and prebiotics in neurogastroenterology
Saulnier, D. M., Ringel, Y., Heyman, M. B., Foster, J. A., Bercik, P., Shulman, R. J., Versalovic, J., Verdu, E. F., Dinan, T. G., Hecht, G., et al. (2013) · Gut Microbes · doi:10.4161/gmic.22973 · Cited by 248 · see citing works
Role of the enteric microbiota in intestinal homeostasis and inflammation
Koboziev, I., Webb, C. R., Furr, K. L., & Grisham, M. B. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.11.008 · Cited by 229 · see citing works
Zwielehner, J., Laßl, C., Hippe, B., Pointner, A., Switzeny, O. J., Remely, M., Elvira, K., Ruckser, R., & Haslberger, A. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028654 · Cited by 211 · see citing works
Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases
Koo, H. L., & DuPont, H. L. (2010) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328333dc8d · Cited by 189 · see citing works
Irritable bowel syndrome: Emerging paradigm in pathophysiology
Lee, Y. J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i10.2456 · Cited by 186 · see citing works
Intestinal epithelial cells as mediators of the commensal–host immune crosstalk
Goto, Y., & Ivanov, I. I. (2013) · Immunology and Cell Biology · doi:10.1038/icb.2012.80 · Cited by 153 · see citing works
Aguilera, M., Vergara, P., & Martínez, V. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12154 · Cited by 119 · see citing works
Self-citationBär, F., Von Koschitzky, H., Roblick, U., Bruch, H. P., Schulze, L., Sonnenborn, U., Böttner, M., & Wedel, T. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01258.x · Cited by 113 · see citing works
Dysbiosis—A consequence of Paneth cell dysfunction
Salzman, N. H., & Bevins, C. L. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.09.006 · Cited by 110 · see citing works
Distrutti, E., Cipriani, S., Mencarelli, A., Renga, B., & Fiorucci, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063893 · Cited by 107 · see citing works
Endogenous Regulation of Visceral Pain via Production of Opioids by Colitogenic CD4+ T Cells in Mice
Boué, J., Basso, L., Cenac, N., Blanpied, C., Rolli–Derkinderen, M., Neunlist, M., Vergnolle, N., & Dietrich, G. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.09.020 · Cited by 104 · see citing works
Brusberg, M., Arvidsson, S., Kang, D., Larsson, H., Lindström, E., & Martinez, V. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5166-08.2009 · Cited by 88 · see citing works
Martı́nez, V., Coutinho, S. V., Thakur, S., Mogil, J. S., Taché, Y., & Mayer, E. A. (1999) · Pain · doi:10.1016/s0304-3959(99)00008-1 · Cited by 87 · see citing works
Self-citationToll-Like Receptor 4 Regulates Chronic Stress-Induced Visceral Pain in Mice
Tramullas, M., Finger, B. C., Moloney, R. D., Golubeva, A. V., Moloney, G., Dinan, T. G., & Cryan, J. F. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.11.004 · Cited by 81 · see citing works
Manipulation of the Gut Microbiota as a Novel Treatment Strategy for Gastrointestinal Disorders
Foxx–Orenstein, A. E., & Chey, W. D. (2012) · The American Journal of Gastroenterology Supplements · doi:10.1038/ajgsup.2012.8 · Cited by 76 · see citing works
Diagnosis of IBS: symptoms, symptom-based criteria, biomarkers or 'psychomarkers'?
Sood, R., Law, G. R., & Ford, A. C. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.127 · Cited by 69 · see citing works
Quigley, E. M. M. (2007) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2007.07.012 · Cited by 67 · see citing works
Terán-Ventura, E., Aguilera, M., Vergara, P., & Martínez, V. (2014) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2014.02.001 · Cited by 59 · see citing works
Self-citationIshihara, S., Tada, Y., Fukuba, N., Oka, A., Kusunoki, R., Mishima, Y., Oshima, N., Moriyama, I., Yuki, T., Kawashima, K., et al. (2013) · Digestion · doi:10.1159/000350054 · Cited by 51 · see citing works
The Role of Pathogenic Microbes and Commensal Bacteria in Irritable Bowel Syndrome
Collins, S., Verdu, E., Denou, E., & Bercik, P. (2009) · Digestive Diseases · doi:10.1159/000268126 · Cited by 49 · see citing works
Irritable bowel syndrome and probiotics: from rationale to clinical use
Verdu, E. F., & Collins, S. M. (2005) · Current Opinion in Gastroenterology · doi:10.1097/01.mog.0000182861.11669.4d · Cited by 34 · see citing works
van der Waaij, D., Vries, J. M. B.-D., & Altes, C. K. (1974) · Journal of Hygiene · doi:10.1017/s0022172400024025 · Cited by 27 · see citing works
Puhl, N. J., Uwiera, R. R. E., Yanke, L. J., Selinger, L. B., & Inglis, G. D. (2011) · Anaerobe · doi:10.1016/j.anaerobe.2011.12.007 · Cited by 26 · see citing works
Emerging role of probiotics and antimicrobials in the management of irritable bowel syndrome
Cash, B. D. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.908278 · Cited by 25 · see citing works
Aguilera, M., Vergara, P., & Martı́nez, V. (2013) · Microbial Ecology · doi:10.1007/s00248-013-0241-0 · Cited by 22 · see citing works
Self-citationThe Gut's Clostridium Cocktail
Barnes, M. J., & Powrie, F. M. (2011) · Science · doi:10.1126/science.1201291 · Cited by 21 · see citing works
Terán-Ventura, E., Roca, M., Martín, M. T., Abarca, M. L., Martı́nez, V., & Vergara, P. (2010) · Microbial Ecology · doi:10.1007/s00248-010-9737-z · Cited by 21 · see citing works
Self-citationIBS with intestinal microbial dysbiosis: a new and clinically relevant subgroup?
Simrén, M. (2014) · Gut · doi:10.1136/gutjnl-2013-306434 · Cited by 21 · see citing works
Jardí, F., Fernández-Blanco, J. A., Martínez, V., & Vergara, P. (2014) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2014.958524 · Cited by 15 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Koboziev I, 2013, Free Radic Biol Med, 68, 122, 10.1016/j.freeradbiomed.2013.11.008 · DOI
Cited by
Sorted by citations
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286 · see citing works
The progress of gut microbiome research related to brain disorders
Zhu, S., Jiang, Y., Xu, K., Cui, M., Ye, W., Zhao, G., Jin, L., & Chen, X. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1705-z · Cited by 419 · see citing works
“pylori [162]; dysbiosis [163] Dysfunction of CB2 and TLR7 [160]; inflammatory hypernociception [161]; TNF-α induced chronic migrain e[163] Lactobacillus, B.”
BackgroundPain regulation by gut microbiota: molecular mechanisms and therapeutic potential
Guo, R., Chen, L., Xing, C., & Liu, T. (2019) · British Journal of Anaesthesia · doi:10.1016/j.bja.2019.07.026 · Cited by 416 · see citing works
Stress and the Microbiota–Gut–Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome
Moloney, R. D., Johnson, A. C., O’Mahony, S. M., Dinan, T. G., Meerveld, B. G., & Cryan, J. F. (2015) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12490 · Cited by 396 · see citing works
Glutamatergic Signaling Along The Microbiota-Gut-Brain Axis
Baj, A., Moro, E., Bistoletti, M., Orlandi, V. T., Crema, F., & Giaroni, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061482 · Cited by 330 · see citing works
“CD is characterized by an inflammatory response developing along the gastrointestinal tract, while inflammation in UC is restricted to the rectum and colon [84].”
BackgroundGut microbiota role in irritable bowel syndrome: New therapeutic strategies
Distrutti, E., Monaldi, L., Ricci, P., & Fiorucci, S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i7.2219 · Cited by 320 · see citing works
Microbiota regulation of the mammalian gut-brain axis
Burokas, A., Moloney, R. D., Dinan, T. G., & Cryan, J. F. (2015) · Advances in applied microbiology · doi:10.1016/bs.aambs.2015.02.001 · Cited by 300 · see citing works
Sherwin, E., Sandhu, K. V., Dinan, T. G., & Cryan, J. F. (2016) · CNS Drugs · doi:10.1007/s40263-016-0370-3 · Cited by 297 · see citing works
“the colon was attenuated following treatment of mice with antibiotics, which was associated with a reduction in visceral pain responses [103].”
BackgroundIrritable bowel syndrome, the microbiota and the gut-brain axis
Raskov, H., Burcharth, J., Pommergaard, H.-C., & Rosenberg, J. (2016) · Gut Microbes · doi:10.1080/19490976.2016.1218585 · Cited by 243 · see citing works
“Visceral pain secondary to the increase in inflammatory cells during dysbiosis following antibiotics can be reverted by administration of lactobacillus and lactic acid producing bacteria.(123)”
BackgroundBosi, A., Banfi, D., Bistoletti, M., Giaroni, C., & Baj, A. (2020) · International Journal of Tryptophan Research · doi:10.1177/1178646920928984 · Cited by 221 · see citing works
Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms
Felice, V. D., Quigley, E. M., Sullivan, A. M., O'Keeffe, G. W., & O'Mahony, S. M. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.03.012 · Cited by 205 · see citing works
Rosean, C. B., Bostic, R. R., Ferey, J. C. M., Feng, T.-Y., Azar, F. N., Tung, K. S. K., Dozmorov, M. G., Smirnova, E., Bos, P. D., & Rutkowski, M. R. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3464 · Cited by 199 · see citing works
“absorbable antibiotic cocktail consisting of bacitracin and neomycin is well-established to specifically deplete bacteria within the gut (46).”
BackgroundGoods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Maccarrone, M., Di Marzo, V., Gertsch, J., Grether, U., Howlett, A. C., Hua, T., Makriyannis, A., Piomelli, D., Ueda, N., & van der Stelt, M. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000600 · Cited by 183 · see citing works
Moody microbes or fecal phrenology: what do we know about the microbiota-gut-brain axis?
Forsythe, P., Kunze, W., & Bienenstock, J. (2016) · BMC Medicine · doi:10.1186/s12916-016-0604-8 · Cited by 155 · see citing works
“However, overall, rodent studies of the effect of antibiotic administration on the development of visceral hypersensitivity have been contradictory [62, 63].”
Fish disease and intestinal microbiota: A close and indivisible relationship
Medina‐Félix, D., Garibay-Valdéz, E., Vargas‐Albores, F., & Martínez‐Porchas, M. (2022) · Reviews in Aquaculture · doi:10.1111/raq.12762 · Cited by 150 · see citing works
The role of gut microbiota in intestinal disease: from an oxidative stress perspective
Sun, Y., Wang, X., Li, L., Zhong, C., Zhang, Y., Yang, X., Li, M., & Yang, C. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1328324 · Cited by 130 · see citing works
The gastrointestinal tract – a central organ of cannabinoid signaling in health and disease
Hasenoehrl, C., Taschler, U., Storr, M., & Schicho, R. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12931 · Cited by 120 · see citing works
Luise, D., Lauridsen, C., Bosi, P., & Trevisi, P. (2019) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-019-0352-7 · Cited by 116 · see citing works
Li, M., Liang, P., Li, Z., Wang, Y., Zhang, G., Gao, H., Shu, W., & Tang, L. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00692 · Cited by 109 · see citing works
Kanwal, S., Joseph, T. P., Owusu, L., Ren, X., Li, M., & Xin, Y. (2018) · Nutrients · doi:10.3390/nu10081003 · Cited by 109 · see citing works
New insights into the pathogenesis and treatment of irritable bowel syndrome
Oświęcimska, J. M., Szymlak, A., Roczniak, W., Girczys-Połedniok, K., & Kwiecień, J. (2017) · Advances in Medical Sciences · doi:10.1016/j.advms.2016.11.001 · Cited by 105 · see citing works
Visceral pain: gut microbiota, a new hope?
Pusceddu, M. M., & Gareau, M. G. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0476-7 · Cited by 100 · see citing works
He, J., Zhou, S., Lv, J., & Zhang, H. (2020) · Theranostics · doi:10.7150/thno.49778 · Cited by 104 · see citing works
“Alterations in the composition of commensal microbiota, such as increments in Bacteroides spp, Clostridium coccoides, and Lactobacillus spp and reduction in Bifidobacterium spp, has been associated with increased levels of secretory IgA in mice [105].”
BackgroundThe gut microbiota as a key regulator of visceral pain
O’Mahony, S. M., Dinan, T. G., & Cryan, J. F. (2016) · Pain · doi:10.1097/j.pain.0000000000000779 · Cited by 98 · see citing works
Wang, L., Ai, C., Wen, C., Qin, Y., Liu, Z., Wang, L., Gong, Y., Su, C., Wang, Z., & Song, S. (2020) · Food & Function · doi:10.1039/d0fo00668h · Cited by 83 · see citing works
Chronic Visceral Pain: New Peripheral Mechanistic Insights and Resulting Treatments
Ford, A. C., Vanner, S. J., Kashyap, P., & Nasser, Y. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.01.045 · Cited by 79 · see citing works
Microbiota: a novel regulator of pain
Defaye, M., Gervason, S., Altier, C., Berthon, J., Ardid, D., Filaire, E., & Carvalho, F. A. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02083-z · Cited by 79 · see citing works
Role of the endocannabinoid system in the regulation of intestinal homeostasis
Cuddihey, H., MacNaughton, W. K., & Sharkey, K. A. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.05.015 · Cited by 79 · see citing works
Antibiotics and the nervous system: More than just the microbes?
Champagne-Jorgensen, K., Kunze, W. A., Forsythe, P., Bienenstock, J., & McVey Neufeld, K.-A. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.12.014 · Cited by 92 · see citing works
The Role of Gut-Derived Microbial Antigens on Liver Fibrosis Initiation and Progression
Chen, D., Le, T. H., Shahidipour, H., Read, S. A., & Ahlenstiel, G. (2019) · Cells · doi:10.3390/cells8111324 · Cited by 67 · see citing works
“can stimulate the release and activation of antimicrobial peptides such as C-type lectins and pro-defensins from intestinal Paneth cells [11,12], activate intestinal B cells to express secretory IgA [13,14], and stimulate the production of protective mucus from colonic goblet cells [15]—all mechanisms that prevent bac…”
BackgroundVisceral Pain and Gastrointestinal Microbiome
Chichlowski, M., & Rudolph, C. (2015) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm15025 · Cited by 65 · see citing works
“Administration of antibiotics to mice for 2 weeks attenuated the visceral pain-related responses to intraperitoneal acetic acid or intra-colonic capsaicin.(46) These changes were associated with increased levels of secretory-IgA, upregulation of the antimicrobial peptide resistin-like molecule beta and”
Long, X., Li, M.-X., Li, L. ‐., Sun, Y., Zhang, W. ‐., Zhao, D. ‐., & Li, Y. (2017) · Neurogastroenterology & Motility · doi:10.1111/nmo.13227 · Cited by 64 · see citing works
The Gut Microbiota-Host Partnership as a Potential Driver of Kawasaki Syndrome
Esposito, S., Polinori, I., & Rigante, D. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00124 · Cited by 64 · see citing works
“In addition, the microbiota can maintain a segregation between intestinal mucosa and bacteria via PRRs, though pathogens might usurp innate signals to their advantage (30) .”
BackgroundWang, P., Tu, K., Cao, P., Yang, Y., Zhang, H., Qiu, X.-T., Zhang, M., Wu, X., Yang, H., & Chen, T. (2021) · Molecular Brain · doi:10.1186/s13041-021-00759-w · Cited by 60 · see citing works
Bai, Y., Ma, K., Li, J., Ren, Z., Zhang, J., & Shan, A. (2022) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-022-00737-9 · Cited by 60 · see citing works
“The gut microbiota plays an important role in maintaining intestinal barrier function and immune balance [48, 49].”
BackgroundThe Role of the Gastrointestinal Microbiota in Visceral Pain
Rea, K., O’Mahony, S. M., Dinan, T. G., & Cryan, J. F. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_115 · Cited by 62 · see citing works
The microbiome and gut endocannabinoid system in the regulation of stress responses and metabolism
Srivastava, R. K., Lutz, B., & Ruiz de Azua, I. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.867267 · Cited by 56 · see citing works
Peripherally acting opioid analgesics and peripherally-induced analgesia
Martı́nez, V., & Abalo, R. (2020) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000558 · Cited by 54 · see citing works
“, 2020) Pain models in rodents (mice, rats): acute somatic pain (tail-flick test, hot plate, mechanical sensitivity), inflammatory somatic pain (mechanical/ thermal allodynia or hyperalgesia after carrageenan/CFA/formalin injection to the paw), neuropathic pain (after sciatic/spinal nerve ligation), visceral pain (wri…”
BackgroundSelf-citationThe microbiome and childhood diseases: Focus on brain‐gut axis
O’Mahony, S. M., Stilling, R. M., Dinan, T. G., & Cryan, J. F. (2015) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.21118 · Cited by 50 · see citing works
Dysregulation of the gut–brain axis in schizophrenia and bipolar disorder
Genedi, M., Janmaat, I. E., Haarman, B. C. M., & Sommer, I. E. (2019) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000499 · Cited by 48 · see citing works
Complexity of antibiotic resistance and its impact on gut microbiota dynamics
Shayista, H., Prasad, M. N. N., Raj, S. N., Prasad, A., Lakshmi, S. J., Ranjini, H. K., Manju, K. G., Ravikumara, Chouhan, R. S., Khohlova, O. Y., et al. (2024) · Engineering Microbiology · doi:10.1016/j.engmic.2024.100187 · Cited by 47 · see citing works
“The presence of pathogenic bacterial components in the intestinal mucosa due to antibiotic-induced dysbiosis triggers an immune response [ 79 ].”
Yang, N., Lan, T., Han, Y., Zhao, H., Wang, C., Xu, Z. C., Zhao, C., Tao, M., Li, H., Song, Y., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0289364 · Cited by 49 · see citing works
“The gut microbiota of mice is disturbed after antibiotic intervention [35].”
Roy, C. I. L., Woodward, M. J., Ellis, R. J., Ragione, R. M. L., & Claus, S. P. (2019) · BMC Veterinary Research · doi:10.1186/s12917-018-1761-0 · Cited by 45 · see citing works
Heng, X., Jiang, Y., & Chu, W. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02552-20 · Cited by 46 · see citing works
IgA Nephropathy: Current Understanding and Perspectives on Pathogenesis and Targeted Treatment
Du, Y.-T., Cheng, T., Liu, C., Zhu, T., Guo, C., Li, S., Rao, X.-R., & Li, J.-P. (2023) · Diagnostics · doi:10.3390/diagnostics13020303 · Cited by 44 · see citing works
Pujo, J., Palma, G. D., Lu, J. G., Galipeau, H. J., Surette, M. G., Collins, S. M., & Berčík, P. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2188874 · Cited by 43 · see citing works
Xu, S., Liu, Z., Lv, M., Chen, Y., & Liu, Y. (2019) · Pathogens and Disease · doi:10.1093/femspd/ftz019 · Cited by 44 · see citing works
Neuroprotective effect of Vitamin K2 against gut dysbiosis associated cognitive decline
Chatterjee, K., Mazumder, P. M., Sarkar, S. R., Saha, R., Chatterjee, A., Sarkar, B., & Banerjee, S. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114252 · Cited by 43 · see citing works
Yan, S., & Kentner, A. C. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.10.007 · Cited by 44 · see citing works
Rosa, C. P., Brancaglion, G. A., Miyauchi-Tavares, T. M., Corsetti, P. P., & de Almeida, L. A. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.06.030 · Cited by 41 · see citing works
Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome
Brierley, S. M., Meerveld, B. G., Sarnelli, G., Sharkey, K. A., Storr, M., & Tack, J. F. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00682-y · Cited by 40 · see citing works
Waitzberg, D. L., Guarner, F., Hojsak, I., Ianiro, G., Polk, D. B., & Sokol, H. (2024) · Advances in Therapy · doi:10.1007/s12325-024-02783-3 · Cited by 44 · see citing works
“…patients [2–5]—is that induced by (or associated with) antibiotic treatments; this has been referred to variously as ‘‘antibiotic-related dysbiosis’’ [6], ‘‘antibiotic-induced dys-biosis’’ [7] and ‘‘antibiotic-associated dysbiosis’’ [8]; we shall adopt the last term, hereafter abbreviated as AAdys.”
Painful interactions: Microbial compounds and visceral pain
van Thiel, I. A. M., Botschuijver, S., de Jonge, W. J., & Seppen, J. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165534 · Cited by 40 · see citing works
Zhang, Y., Liu, Q., Yu, Y., Wang, M., Wen, C., & He, Z. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00628 · Cited by 39 · see citing works
Perna, A., Hay, E., Contieri, M., Luca, A. D., Guerra, G., & Lucariello, A. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29430 · Cited by 38 · see citing works
Zhu, H., Zhou, Y., Qi, Y., Ji, R., Zhang, J., Qian, Z., Wu, C., Tan, J., Shao, L., & Chen, D. (2019) · Food & Function · doi:10.1039/c9fo00960d · Cited by 37 · see citing works
Takahashi, K., Khwaja, I., Schreyer, J. R., Bulmer, D. C., Peiris, M., Terai, S., & Aziz, Q. (2021) · Crohn s & Colitis 360 · doi:10.1093/crocol/otab073 · Cited by 33 · see citing works
Antibiotic Driven Changes in Gut Motility Suggest Direct Modulation of Enteric Nervous System
Delungahawatta, T., Amin, J. Y., Stanisz, A. M., Bienenstock, J., Forsythe, P., & Kunze, W. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00588 · Cited by 32 · see citing works
“High doses of bacitracin and neomycin were initially tested because they have been used in many prior experimental studies demonstrating neurophysiological and behavioral effects of antibiotic–mediated disturbances in the microbiota (Verdú et al., 2006; Bercik et al., 2011; O’Mahony et al., 2014; Aguilera et al., 2015…”
BackgroundInfluentialJohnson, K. V. ‐., & Burnet, P. W. J. (2020) · BMC Neuroscience · doi:10.1186/s12868-020-00583-3 · Cited by 31 · see citing works
Zhang, T., Ding, H., Chen, L., Lin, Y., Gong, Y., Pan, Z., Zhang, G., Xie, K., Dai, G., & Wang, J. (2021) · Metabolites · doi:10.3390/metabo11080487 · Cited by 32 · see citing works
“Antibiotic-induced dysbiosis of the gut microbiota has been extremely useful in inferring the causal role of microbial dysbiosis with many host phenotypes [8,9].”
BackgroundDothel, G., Chang, L., Shih, W., Barbaro, M. R., Cremon, C., Stanghellini, V., Ponti, F. D., Mayer, E. A., Barbara, G., & Sternini, C. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13688 · Cited by 30 · see citing works
Sun, B.-Y., He, W., Yang, H., Tian, D.-Y., Jian, P.-Y., Wu, K., Yang, C.-G., & Song, X. (2022) · Aquaculture · doi:10.1016/j.aquaculture.2022.737969 · Cited by 30 · see citing works
Wang, F., Li, N., Ni, S.-M., Yu, M., Kang, W., Sun, H., Fu, Y., Liu, Y., & Lv, D. (2023) · Nutrients · doi:10.3390/nu15102407 · Cited by 29 · see citing works
“Some studies focusing on modulating microbiota and metabolites have reported reduced clinical phenotypes in IgAN mice [15,16].”
BackgroundKappéter, Á., Sipos, D., Varga, A., Vigvári, S., Halda-Kiss, B., & Péterfi, Z. (2023) · Microorganisms · doi:10.3390/microorganisms11082083 · Cited by 29 · see citing works
“showed that inflammatory hypernociception was induced by lipopolysaccharide (LPS), TNF-α, and IL-1β, and the chemokine CXCL1 was reduced in germ-free mice; such result was induced by prostaglandins and dopamine [1,25,26].”
BackgroundThe Role of Gut Microbiome in Irritable Bowel Syndrome: Implications for Clinical Therapeutics
Zhao, Y., Zhu, S., Dong, Y., Xie, T., Chai, Z., Gao, X., Dai, Y., & Wang, X. (2024) · Biomolecules · doi:10.3390/biom14121643 · Cited by 30 · see citing works
“The interplay between the intestinal microbiome and IgA production highlights the importance of studying their impact on conditions like IBS [199].”
Collinet, A., Grimm, P., Julliand, S., & Julliand, V. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.646294 · Cited by 27 · see citing works
Enterochromaffin Cells: Sentinels to Gut Microbiota in Hyperalgesia?
Xu, X., Chen, R., Zhan, G., Wang, D., Tan, X., & Xu, H. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.760076 · Cited by 29 · see citing works
The Intestinal Microbiota in the Irritable Bowel Syndrome
Collins, S. M. (2016) · International Review of Neurobiology · doi:10.1016/bs.irn.2016.08.003 · Cited by 30 · see citing works
Roles of Neuronal TRP Channels in Neuroimmune Interactions
López‐Requena, A., Boonen, B., Gerven, L. V., Hellings, P. W., Alpizar, Y. A., & Talavera, K. (2017) · CRC Press eBooks · doi:10.4324/9781315152837-15 · Cited by 26 · see citing works
Choudhury, A., Ortiz, P. S., Young, M., Mahmud, M. T., Stoffel, R. T., Greathouse, K. L., & Kearney, C. M. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02014-23 · Cited by 25 · see citing works
“However, large-scale antibiotic treatment programs create unnecessary risks of increasing antibiotic resistance (12–14) and microbial dysbiosis (15, 16).”
BackgroundVisceral Pain and Psychiatric Disorders
Felice, V. D., Moloney, R. D., Cryan, J. F., Dinan, T. G., & O’Mahony, S. M. (2015) · Modern trends in psychiatry · doi:10.1159/000435936 · Cited by 25 · see citing works
Sun, N., Cao, L.-S., Xia, W.-Y., Wang, J., & Wu, Q. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03500-9 · Cited by 24 · see citing works
“Concurrently, cannabinoid receptor 2 (CB2) is upregulated while CB1 and µ-opioid receptors are downregulated, alleviating pain responses and demonstrating the co-regulatory role of gut microbiota in neuro-immune interactions [94].”
Song, S., Liu, J., Zhang, F., & Hong, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-72202-4 · Cited by 24 · see citing works
Hurtado‐Lorenzo, A., Honig, G., Weaver, S. A., Larkin, P. B., & Heller, C. A. (2021) · Crohn s & Colitis 360 · doi:10.1093/crocol/otab034 · Cited by 24 · see citing works
Bifidobacterium breve MCC1274 with glycosidic activity enhances in vivo isoflavone bioavailability
Yao, R., Wong, C. B., NAKAMURA, K., Mitsuyama, E., Tanaka, A., Kuhara, T., Odamaki, T., & Xiao, J. (2019) · Beneficial Microbes · doi:10.3920/bm2018.0179 · Cited by 23 · see citing works
Vancomycin-induced gut dysbiosis duringPseudomonas aeruginosapulmonary infection in a mice model
Rosa, C. P., Pereira, J. A., Santos, N. C. D. M., Brancaglion, G. A., Silva, E. N., Tagliati, C. A., Novaes, R. D., Corsetti, P. P., & de Almeida, L. A. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.4ab0919-432r · Cited by 23 · see citing works
Giardia lamblia infection increases risk of chronic gastrointestinal disorders
Dormond, M., Gutiérrez, R. L., & Porter, C. K. (2016) · Tropical Diseases Travel Medicine and Vaccines · doi:10.1186/s40794-016-0030-0 · Cited by 22 · see citing works
“In a healthy host, it may be that these infections trigger the intestinal dysbiosis and altered sensory perception common noted in many FGDs [22].”
BackgroundInfluentialThe divergent restoration effects of Lactobacillus strains in antibiotic-induced dysbiosis
Shi, Y., Kellingray, L., Gall, G. L., Zhao, J., Zhang, H., Narbad, A., Zhai, Q., & Chen, W. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.10.011 · Cited by 21 · see citing works
Litou, C., Effinger, A., Kostewicz, E. S., Box, K. J., Fotaki, N., & Dressman, J. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12983 · Cited by 21 · see citing works
Alshammari, K. M., Alotaibi, F., Alsugheir, F., Aldawoud, M., Alolayan, A. A. M., Algarni, M., Sabatin, F., Mohammad, M. F., Alosaimi, A., Sanai, F. M., et al. (2023) · Cancers · doi:10.3390/cancers16010133 · Cited by 19 · see citing works
“While antibiotics are indispensable in treating bacterial infections, their indiscriminate use can lead to dysbiosis, potentially affecting the gut microbiota’s beneficial roles [21,22].”
Hearn-Yeates, F., Horne, A. W., O’Mahony, S. M., & Saunders, P. T. K. (2024) · Reproduction and Fertility · doi:10.1530/raf-23-0085 · Cited by 24 · see citing works
Evaluation of Escherichia coli pathotypes associated with Irritable Bowel Syndrome
Dogan, B., Belcher-Timme, H. F., Dogan, E. I., Jiang, Z., DuPont, H. L., Synder, N., Yang, S. C., Chandler, B., Scherl, E., & Simpson, K. W. (2018) · FEMS Microbiology Letters · doi:10.1093/femsle/fny249 · Cited by 19 · see citing works
Chamorro, N., Montero, D. A., Gallardo, P., Farfán, M. J., Mauricio Contreras, G., la Fuente, M. D., Dubois‐Camacho, K., Hermoso, M. A., Quera, R., Pizarro‐Guajardo, M., et al. (2021) · Microbial Cell · doi:10.15698/mic2021.09.760 · Cited by 21 · see citing works
Cannabinoid Receptors in Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance
Taschler, U., Hasenoehrl, C., Storr, M., & Schicho, R. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_105 · Cited by 20 · see citing works
Animal models of visceral pain and the role of the microbiome
West, C. L., & Neufeld, K. M. (2021) · Neurobiology of Pain · doi:10.1016/j.ynpai.2021.100064 · Cited by 17 · see citing works
“Similarly, another study has shown that treatment of adult mice with broad-spectrum antibiotics for two weeks resulted in bacterial disruption characterized by increased Bacteroides spp, Clostridium coccoides, and Lactobacillus spp and reduced Bifidobacterium spp (Aguilera et al., 2015).”
BackgroundMethodInfluential<i>Weizmannia coagulans</i>: an Ideal Probiotic for Gut Health
Zhang, S., Li, P., Lee, S., Wang, Y., Tan, C., & Shang, N. (2023) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250002 · Cited by 18 · see citing works
“Many factors including environmental (diet, alcohol, and antibiotics) and genetic determinants can disrupt the balanced microbiota into a state of dysbiosis [14-16] .”
Antibiotic-associated Gut Dysbiosis
Ramakrishna, B., & Patankar, R. V. (2023) · Journal of the Association of Physicians of India · doi:10.59556/japi.71.0381 · Cited by 17 · see citing works
“4 Microbiota helps in processing nutrients, producing essential compounds, shaping the immune system, and maturing the GI system.”
The emerging role of the endocannabinoidome-gut microbiome axis in eating disorders
Mir, H.-D., Giorgini, G., & Marzo, V. D. (2023) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2023.106295 · Cited by 16 · see citing works
Yang, J., Wang, L., Mei, M., Guo, J., Yang, X., & Liu, S. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00733-9 · Cited by 14 · see citing works
“Antibiotic-treated mice showed downregulation of CB1 [34], while probiotic supplement upregulated CB1 [15].”
BackgroundCannabis use in the United States and its impact on gastrointestinal health
Alshaarawy, O., Balasubramanian, G., & Venkatesan, T. (2023) · Nutrition in Clinical Practice · doi:10.1002/ncp.11111 · Cited by 15 · see citing works
“104 Mutations in the Myd88 gene disrupted toll ‐ like receptor – mediated bacterial – host interactions, resulting in changes in CB1R messenger RNA levels in the colon.”
Neonatal abstinence syndrome and the gastrointestinal tract
Maguire, D. J., & Groer, M. E. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.10.006 · Cited by 14 · see citing works
Inflammasome Signaling Regulates the Microbial–Neuroimmune Axis and Visceral Pain in Mice
Aguilera, M., Rossini, V., Hickey, A., Simnica, D., Grady, F., Felice, V. D., Moloney, A., Pawley, L. C., Fanning, A., McCarthy, L., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158336 · Cited by 13 · see citing works
Self-citationAntibiotics Modulate Intestinal Regeneration
Díaz-Díaz, L. M., Rosario-Meléndez, N., Rodríguez-Villafañe, A., Figueroa-Vega, Y. Y., Pérez-Villafañe, O. A., Colón-Cruz, A. M., Rodríguez-Sánchez, P. I., Cuevas-Cruz, J. M., Malavez-Cajigas, S. J., Maldonado-Chaar, S. M., et al. (2021) · Biology · doi:10.3390/biology10030236 · Cited by 13 · see citing works
Irritable Bowel Syndrome in Terms of Changes in the Microbiota
Ivashkin, V. T., & Zolnikova, O. Y. (2019) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2019-29-1-84-92 · Cited by 13 · see citing works
Florfenicol-induced dysbiosis impairs intestinal homeostasis and host immune system in laying hens
Yu, K., Choi, I., Kim, M., Pyung, Y. J., Lee, J.-S., Choi, Y., Won, S., Kim, Y., Park, B.-C., Han, S. H., et al. (2025) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-025-01186-w · Cited by 12 · see citing works
“Other intestinal effects of anti-biotics include the reduced expression of tight junction proteins [16, 17], disruption of the mucus barrier [18], impairment of goblet cell function [19], and a weakening of the gut barrier function in the host [20].”
Mao, M., Zhou, Y., Jiao, Y., Yin, S., Cheung, C., Yu, W., Gao, P., & Yang, L. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.975376 · Cited by 14 · see citing works
“pharmacology and therapeutics and Gut were cited most frequently with 57 times, during the past 20 years, followed by those in Neurogastroenterology and Motility (35), Nature Medicine (30), Scientific Reports (24), Nature Neuroscience (23), Neuroscience (21), Proceedings of the National Academy of Sciences of the Unit…”
BackgroundPain Bugs: Gut Microbiota and Pain Disorders
Rea, K., O’Mahony, S. M., Dinan, T. G., & Cryan, J. F. (2019) · Current Opinion in Physiology · doi:10.1016/j.cophys.2019.10.001 · Cited by 12 · see citing works
Hertati, A., Hayashi, S., Ogata, H., Miyata, K., Kato, R., Yamamoto, T., & Kadowaki, M. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05647 · Cited by 12 · see citing works
Liu, B., Huang, C., Li, X., Yu, H., Xia, Y., Liu, K., You, X., & Wu, J. (2025) · Advanced Science · doi:10.1002/advs.202416348 · Cited by 11 · see citing works
Short-Chain Fatty Acids as Bacterial Enterocytes and Therapeutic Target in Diabetes Mellitus Type 2
Neag, M. A., Craciun, A. E., Inceu, A.-I., Burlacu, D.-E., Crăciun, C.-I., & Buzoianu, A. D. (2022) · Biomedicines · doi:10.3390/biomedicines11010072 · Cited by 12 · see citing works
“Gut dysbiosis causes alteration in host microbial interactions of IBS patients, leading to dysregulated local immune response, which might contribute to intestinal sensorial and secretomotor disruption in these patients [14].”
Influential
- Authors
- Aguilera, M., Cerdà-Cuéllar, M., & Martínez, V
- Affiliations
- Universitat Autònoma de Barcelona (ES)
- ORCID
- Aguilera, M
- Venue
- Gut Microbes
- Publisher
- Informa UK Limited
- Published
- 2015-01-02
- Volume
- 6
- Issue
- 1
- Pages
- 10-23
- ISSN
- 1949-0976 (ISSN-L)
- 1949-0984
- PMC
- PMC4615720
- OpenAlex
- W1968505351
- Semantic Scholar
- 3b2d71a386ebd6c4571e8ad8619fefde66627728
- Cited by
- 162
- References
- 67
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 13 · 2023: 22 · 2022: 14 · 2021: 19 · 2020: 10 · 2019: 21 · 2018: 10 · 2017: 11 · 2016: 15 · 2015: 6
- FWCI
- 10.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gut Microbes (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Generalitat de Catalunya (2009SGR708, BFU2009-08229)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
- Keywords
- antibiotic-induced dysbiosis, gut microbiota, irritable bowel syndrome, visceral pain, colonic motility, secretory IgA, RegIIIγ, Toll-like receptors, resistin-like molecule beta, CB2 receptor, mu-opioid receptor, goblet cells, Bifidobacterium, Lactobacillus, Clostridium coccoides, Bacteroides
- MeSH terms
- Gastrointestinal Microbiome, Animals, Anti-Bacterial Agents, Colon, Female, Mice, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review